200 related articles for article (PubMed ID: 25159681)
41. Status and prognosis of lymph node metastasis in patients with cardia cancer - a systematic review.
Okholm C; Svendsen LB; Achiam MP
Surg Oncol; 2014 Sep; 23(3):140-6. PubMed ID: 24953457
[TBL] [Abstract][Full Text] [Related]
42. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
43. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
44. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
[TBL] [Abstract][Full Text] [Related]
45. Serum tumor-associated glycoprotein 72, a helpful predictor of lymph nodes invasion in esophagogastric junction adenocarcinoma.
Xu Y; Chen Y; Wei L; Lai S; Zheng W; Wu F
Biochem Biophys Res Commun; 2019 Jan; 509(1):133-137. PubMed ID: 30579602
[TBL] [Abstract][Full Text] [Related]
46. [Risk factors of early recurrence and prognosis for patients with adenocarcinoma of gastroesophageal junction after curative resection].
Tang P; Zhang HD; Yu ZT
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(45):3594-7. PubMed ID: 24534309
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China.
Deng J; Zhang R; Pan Y; Wang B; Wu L; Jiao X; Bao T; Hao X; Liang H
Surgery; 2014 Jul; 156(1):64-74. PubMed ID: 24929759
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].
Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705
[TBL] [Abstract][Full Text] [Related]
49. Identification of biomarkers associated with diagnosis and prognosis of gastroesophageal junction adenocarcinoma-a study based on integrated bioinformatics analysis in GEO and TCGA database.
Song D; Tian J; Hu Y; Wei Y; Lu H; Wang Y; Guan Q; Zhou Y
Medicine (Baltimore); 2020 Dec; 99(51):e23605. PubMed ID: 33371094
[TBL] [Abstract][Full Text] [Related]
50. Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction.
Zhou Z; Xie X; Hao N; Diao D; Song Y; Xia P; Dang C; Zhang H
Curr Med Res Opin; 2018 Jun; 34(6):963-970. PubMed ID: 29338535
[TBL] [Abstract][Full Text] [Related]
51. Expression of vascular endothelial growth factor C correlates with lymphatic vessel density and prognosis in human gastroesophageal junction carcinoma.
Yang LP; Fu LC; Guo H; Xie LX
Onkologie; 2012; 35(3):88-93. PubMed ID: 22414971
[TBL] [Abstract][Full Text] [Related]
52. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement.
Gamboa AM; Kim S; Force SD; Staley CA; Woods KE; Kooby DA; Maithel SK; Luke JA; Shaffer KM; Dacha S; Saba NF; Keilin SA; Cai Q; El-Rayes BF; Chen Z; Willingham FF
Cancer; 2016 Jul; 122(14):2150-7. PubMed ID: 27142247
[TBL] [Abstract][Full Text] [Related]
53. Significance of lymph nodal metastases in treatment of esophagogastric adenocarcinoma.
Aikou T; Shimazu H; Takao T; Baba M; Natsugoe S; Simada M
Lymphology; 1992 Mar; 25(1):31-6. PubMed ID: 1569781
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
55. Analysis of micrometastatic disease in histologically negative lymph nodes of patients with adenocarcinoma of the distal esophagus or gastric cardia.
Buskens CJ; Ten Kate FJ; Obertop H; Izbicki JR; van Lanschot JJ
Dis Esophagus; 2008; 21(6):488-95. PubMed ID: 18840133
[TBL] [Abstract][Full Text] [Related]
56. [Clinical characteristics of lymph node metastasis in Siewert type II adenocarcinoma of the gastroesophageal junction].
Li SM; Li ZY; Ji X
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):288-91. PubMed ID: 23985258
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
[TBL] [Abstract][Full Text] [Related]
58. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.
Galizia G; Lieto E; Auricchio A; Cardella F; Mabilia A; Diana A; Castellano P; De Vita F; Orditura M
PLoS One; 2017; 12(4):e0173619. PubMed ID: 28380037
[TBL] [Abstract][Full Text] [Related]
60. Over expression of p21-activated kinase 7 associates with lymph node metastasis in esophageal squamous cell cancers.
He S; Liu M; Zhang W; Xu N; Zhu H
Cancer Biomark; 2016; 16(2):203-9. PubMed ID: 26682509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
